Relief Therapeutics is in Advanced Clinical Development to Treat Severe COVID-19 Patients
RLFTF

COVID-19, General, Healthcare

This morning, several media channels including the CNBC, paid attention to the Swiss biopharmaceutical company Relief Therapeutics (OTCQB: $RLFTF), focusing on its share that grew by a sensational 38,000% this year. The main reason is RLF-100™ (aviptadil), an advanced clinical development for the treatment of severe COVID-19 patients. Specialization and Expertise Relief specializes in the…

Relief Therapeutics is in Advanced Clinical Development to Treat Severe COVID-19 Patients
RLFTF

COVID-19, General, Healthcare

This morning, several media outlets, including the CNBC, pay attention to the Swiss biopharmaceutical company Relief Therapeutics (OTCQB: $RLFTF), focusing on its share that grew by a sensational 38,000% this year. The main reason is RLF-100™ (aviptadil), an advanced clinical development for the treatment of severe COVID-19 patients. Is RLF-100™ a much needed specialization? Relief…

The ThermalPass Is Gaining Popularity: Hospitals And Governments Are Convinced
PAI.v

COVID-19, General, Healthcare, Technology

Breakout Stocks   Corona Virus Stocks Predictiv AI, Inc. (TSX-V: PAI) (OTC: INOTF) (FSE: 71TA) is gaining confidence today by announcing several purchase orders for the ThermalPass in various market segments. This shows that the innovative temperature screening system for Covid-19 and other viruses is clearly being noticed on the (international) market. The numbers are increasing after…

Arcis Resources Corp. Possesses Over 1.4 Million Square Meters: This Cannabis Hits Different!
ARCS

CBD, General

Breakout Stocks   Corona Virus Stocks  The American cannabis corporation Arcis Resources Corp. (OTCMKTS: ARCS) made several big announcements in December, which clearly had an effect on its share. It has increased by over 1,300% and hasn’t dropped ever since. It’s the power of a share worth less than $1 to rise quickly on promising reporting, especially…

Enzolytics Breaks New Ground: Merger With BioClonetics Immunotherapeutics Is Compelling
ENZC

COVID-19, General, Healthcare

Breakout Stocks   Corona Virus Stocks  Traders Tips The last month of a stunning year is still going strong for Enzolytics, Inc. (OTC: ENZC), which announced earlier this month that it has completed its merger with BioClonetics Immunotherapeutics. The result is an increasing demand for this volatile stock, which currently has a value of almost $0.09 per…

Tesoro Enterprises Becomes HUMBL, Inc: Is the Bigger International Stage Within Reach?
TSNP

Business, General, Technology

Breakout Stocks   Corona Virus Stocks  Earlier this week, Tesoro Enterprises, Inc. (OTCMKT: TSNP) already announced to its shareholders and investors that HUMBL would hold an investor call on Wednesday, December 9, 2020. The main reason for the call was to get to know HUMBL President and CEO, Brian Foote. Subsequently, the technologies, business model and roadmap…

Therma’s CoviSafe™ Meets the Standards of the FDA and Health Canada: Will 2021 Be a Year of Success?
THRM.v

General

Breakout Stocks   Corona Virus Stocks  This week Therma Bright (TSXV: THRM) announced the sensational test results of a highly accurate feasibility study showing that the potential saliva test CoviSafe™ has a test sensitivity of 80% and a specificity of more than 90%. The test is intended to quickly and efficiently detect Covid-19 in patients and meets…

BioCryst Pharmaceuticals On Our Radar: Can ORLADEYO™ Cause Another Revival?
BCRX

General, Healthcare

Breakout Stocks   Corona Virus Stocks  This week BioCryst Pharmaceuticals, Inc. ($BCRX) announced FDA approval of ORLADEYO™ (berotralstat), the first oral and once-daily therapy to prevent seizures in hereditary angioedema patients. To top it all off, the company subsequently announced a $325 million financing together with Royalty Pharma and Athyrium Capital Management. ORLADEYO™ ORLADEYO™ offers patients with…